ADVANCED DRUG DELIVERY REVIEWS
主办单位:Elsevier
出版周期:
未知
语种:英文
国际刊号:0169-409X
期刊预警:
不在预警名单中
投稿经验(5)
医脉通用户3487467
2022-05-16 10:18:05
整个流程比ccc和ccr都慢两倍 唉
医脉通用户8734871
2022-04-22 22:28:43
审稿速度为1个月 投稿是否录用修改后录用 
很好中
医脉通用户2194870
2021-11-14 10:55:55
已经投稿两个月了 仍然处在under consideration
医脉通用户2355472
2020-09-29 12:24:51
当时也只是抱着试一试的心态投的,没想到能中,希望这个期刊以后能够越来越好!
医脉通用户4904354
2020-02-16 06:33:58
总体要求较严,审稿周期很慢,大修后还要返回到审稿人手里,又会耽误2个月,急需文章的人还是调研下再投吧
发布我的投稿经验
刊物简介
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.